Loading market data...

Akums Drugs and Pharmaceuticals IPO

CDMO/Pharma - Listed on 06 August 2024

+6.8% listing gain
Issue Price (Upper)
Rs 679
Listing Price
Rs 725
Closing Price (NSE)
Rs 796.25
Total Subscription
63.39x

Akums Drugs and Pharmaceuticals IPO listing summary

Akums Drugs and Pharmaceuticals (CDMO/Pharma) closed its IPO window in 2024 and listed on NSE and BSE on 06 August 2024 at an upper band issue price of Rs 679, opening at Rs 725 for a listing gain of +6.8% and closing day one at Rs 796.25 (+17.3% on closing basis). The IPO was subscribed 63.39x overall - QIB 90.09x, HNI/NII 42.08x, Retail 20.58x. The total issue size was Rs 1,856.74 Cr (Fresh Issue Rs 680 Cr, OFS Rs 1176.74 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+6.77%
Listing Gain (Close)
+17.27%
Day Change After Listing
+10.49%
Retail Quota
10.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB90.09x
HNI / NII42.08x
Retail20.58x
Overall63.39x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 11.37x
Day 24.43x
Day 3 (Final)63.39x

Akums Drugs and Pharmaceuticals IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 175+14.73%
Day 2Rs 180+19.15%
Day 3Rs 193+22.09%
Day 4Rs 193+26.51%
Day 5Rs 180+28.42%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
14.7%-28.4%
IPOGyani AI Prediction
-
Actual Listing Gain
+6.8%

Issue & financials

Issue SizeRs 1,856.74 Cr
Fresh IssueRs 680 Cr
OFSRs 1,176.74 Cr
IPO PE38.50
Peer / Sector PE32.00
PE vs Sector Ratio1.20
Latest EBITDA (Cr)3.73
Debt / Equity0.69

Market context at listing

How the broader market moved around the Akums Drugs and Pharmaceuticals IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+1.73%
Nifty 1W Return+1.33%
Nifty 1M Return+4.05%
Nifty during IPO window+0.46%

Akums Drugs and Pharmaceuticals IPO - FAQs

What was the listing gain of Akums Drugs and Pharmaceuticals IPO?

Akums Drugs and Pharmaceuticals IPO listed at +6.8% versus the upper issue price of Rs 679 on 06 August 2024.

How many times was Akums Drugs and Pharmaceuticals IPO subscribed?

Akums Drugs and Pharmaceuticals IPO was subscribed 63.39x overall. QIB portion was subscribed 90.09x, HNI / NII 42.08x and Retail 20.58x.

What was the IPO GMP for Akums Drugs and Pharmaceuticals?

IPO GMP started at Rs 175 on Day 1 and moved to Rs 180 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2024

Browse listed IPOs by year